218 related articles for article (PubMed ID: 28747140)
1. Mitochondrial assembly receptor expression is an independent prognosticator for patients with oral tongue squamous cell carcinoma.
Su YY; Chen CH; Chien CY; Lin WC; Huang WT; Li SH
J Renin Angiotensin Aldosterone Syst; 2017; 18(3):1470320317717904. PubMed ID: 28747140
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance and function of mammalian target of rapamycin in tongue squamous cell carcinoma.
Li SH; Chien CY; Huang WT; Luo SD; Su YY; Tien WY; Lan YC; Chen CH
Sci Rep; 2017 Aug; 7(1):8178. PubMed ID: 28811537
[TBL] [Abstract][Full Text] [Related]
3. The clinical impact of angiotensin-(1-7)/mitochondrial assembly receptor axis in esophageal squamous cell carcinoma patients receiving curative esophagectomy.
Chen YH; Lu HI; Lo CM; Huang CC; Hsiao CC; Li SH
J Formos Med Assoc; 2020 Jan; 119(1 Pt 2):310-318. PubMed ID: 31202501
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of renin-angiotensin system blockade in esophageal squamous cell carcinoma.
Chen YH; Huang CH; Lu HI; Chen CH; Huang WT; Hsieh MJ; Rau KM; Chang AY; Lin WC; Li SH
J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1185-92. PubMed ID: 24961505
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of cannabinoid CB1 and CB2 receptors expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients' survival.
Theocharis S; Giaginis C; Alexandrou P; Rodriguez J; Tasoulas J; Danas E; Patsouris E; Klijanienko J
Tumour Biol; 2016 Mar; 37(3):3647-56. PubMed ID: 26459312
[TBL] [Abstract][Full Text] [Related]
6. Metallothionein expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patient survival.
Theocharis S; Klijanienko J; Giaginis C; Rodriguez J; Jouffroy T; Girod A; Point D; Tsourouflis G; Sastre-Garau X
Histopathology; 2011 Sep; 59(3):514-25. PubMed ID: 22034891
[TBL] [Abstract][Full Text] [Related]
7. [Correlation between prognosis and cell proliferation, apoptosis in squamous cell carcinoma of tongue].
Yang YP; Qing HY; Cao Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2003 Jan; 38(1):31-4. PubMed ID: 12760773
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 9 mediates invasion and predicts prognosis in squamous cell carcinoma of the mobile tongue.
Kauppila JH; Korvala J; Siirilä K; Manni M; Mäkinen LK; Hagström J; Atula T; Haglund C; Selander KS; Saarnio J; Karttunen TJ; Lehenkari PP; Salo T
J Oral Pathol Med; 2015 Sep; 44(8):571-7. PubMed ID: 25338738
[TBL] [Abstract][Full Text] [Related]
9. MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor.
Li J; Huang H; Sun L; Yang M; Pan C; Chen W; Wu D; Lin Z; Zeng C; Yao Y; Zhang P; Song E
Clin Cancer Res; 2009 Jun; 15(12):3998-4008. PubMed ID: 19509158
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Hippo pathway effector TAZ in tongue squamous cell carcinoma: correlation with clinicopathological features and patients' prognosis.
Wei Z; Wang Y; Li Z; Yuan C; Zhang W; Wang D; Ye J; Jiang H; Wu Y; Cheng J
J Oral Pathol Med; 2013 Nov; 42(10):747-54. PubMed ID: 23551691
[TBL] [Abstract][Full Text] [Related]
11. Cortactin is a prognostic marker for oral squamous cell carcinoma and its overexpression is involved in oral carcinogenesis.
Liu YC; Ho HC; Lee MR; Yeh CM; Tseng HC; Lin YC; Chung JG
Environ Toxicol; 2017 Mar; 32(3):799-812. PubMed ID: 27148699
[TBL] [Abstract][Full Text] [Related]
12. Cytoplasmic neuropilin 2 is associated with metastasis and a poor prognosis in early tongue cancer patients.
Ong HS; Gokavarapu S; Xu Q; Tian Z; Li J; Ji T; Zhang CP
Int J Oral Maxillofac Surg; 2017 Oct; 46(10):1205-1219. PubMed ID: 28602571
[TBL] [Abstract][Full Text] [Related]
13. [Squamous-cell carcinoma of the tongue: treatment results and prognosis].
Zwetyenga N; Majoufre-Lefebvre C; Siberchicot F; Demeaux H; Pinsolle J
Rev Stomatol Chir Maxillofac; 2003 Feb; 104(1):10-7. PubMed ID: 12644785
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of E2F-1 is associated with increased disease-free survival in squamous cell carcinoma of the anterior tongue.
Kwong RA; Nguyen TV; Bova RJ; Kench JG; Cole IE; Musgrove EA; Henshall SM; Sutherland RL
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3705-11. PubMed ID: 14506162
[TBL] [Abstract][Full Text] [Related]
15. Expression and Clinical Significance of Concomitant FAK/SRC and p-Paxillin in Mobile Tongue Squamous Cell Carcinoma.
Theocharis S; Kotta-Loizou I; Giaginis C; Alexandrou P; Danas E; Tsourouflis G; Tsoukalas N; Coutts RH; Tasoulas J; Klijanienko J
Anticancer Res; 2017 Mar; 37(3):1313-1319. PubMed ID: 28314297
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of hypoxia markers in T2-staged oral tongue cancer.
Roh JL; Cho KJ; Kwon GY; Ryu CH; Chang HW; Choi SH; Nam SY; Kim SY
Oral Oncol; 2009 Jan; 45(1):63-8. PubMed ID: 18620902
[TBL] [Abstract][Full Text] [Related]
17. c-Met expression as an indicator of survival outcome in patients with oral tongue carcinoma.
Kim CH; Koh YW; Han JH; Kim JW; Lee JS; Baek SJ; Hwang HS; Choi EC
Head Neck; 2010 Dec; 32(12):1655-64. PubMed ID: 20848408
[TBL] [Abstract][Full Text] [Related]
18. Critical roles of Wnt5a-Ror2 signaling in aggressiveness of tongue squamous cell carcinoma and production of matrix metalloproteinase-2 via ΔNp63β-mediated epithelial-mesenchymal transition.
Sakamoto T; Kawano S; Matsubara R; Goto Y; Jinno T; Maruse Y; Kaneko N; Hashiguchi Y; Hattori T; Tanaka S; Kitamura R; Kiyoshima T; Nakamura S
Oral Oncol; 2017 Jun; 69():15-25. PubMed ID: 28559016
[TBL] [Abstract][Full Text] [Related]
19. Extracellular interleukin-17F has a protective effect in oral tongue squamous cell carcinoma.
Almahmoudi R; Salem A; Sieviläinen M; Sundquist E; Almangush A; Toppila-Salmi S; Paavonen T; Salo T; Al-Samadi A
Head Neck; 2018 Oct; 40(10):2155-2165. PubMed ID: 29761594
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of carbonic anhydrase IX and Ki-67 expression in squamous cell carcinoma of the tongue.
Kim SJ; Shin HJ; Jung KY; Baek SK; Shin BK; Choi J; Kim BS; Shin SW; Kim YH; Kim JS; Oosterwijk E
Jpn J Clin Oncol; 2007 Nov; 37(11):812-9. PubMed ID: 18057013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
